EVALUATION OF THE INCREASE IN MENTAL CAPACITY AND AFFECTIVITY AS A FUNCTION OF ORAL TREATMENT WITH PROCAINE V HEMATOPORPHIRINE IN PERSONS OVER 55 YEARS OLD
Not Applicable
- Conditions
- -F99 Mental disorder, not otherwise specifiedMental disorder, not otherwise specifiedF99
- Registration Number
- PER-006-00
- Lead Sponsor
- ABORATORIO FARMACEUTICO PERUANO GERMANO S.A. (LAPERGERSA),
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Over 55 years old
Regular residents of private homes or asylums
In good physical and mental health
Exclusion Criteria
Significant impairment of brain function.
Subjects with acute or chronic diseases that make evaluations impossible or distort. Neoplastic diseases.
Subjects under treatment with Procaine, vitamins, sedatives or psychotropics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method